Recombinant Rat MAG

Recombinant Rat MAG

Product No.: M1243

[product_table name="All Top" skus="M1243"]

- -
- -
Alternate Names
Siglec-4a, GMA
Product Type
Recombinant Protein
Expression Host
NS0 Cells
Species
Rat

- -
- -
Select Product Size
- -
- -

Background

Myelin-associated glycoprotein (MAG) is a transmembrane proteins that is a component of myelin in the central and peripheral nervous system.1 It promotes neurite outgrowth during the embryonic development, but inhibits axonal regeneration in the adult nervous system.1 MAG mediates cell-cell interactions between myelinating glial cells and neurons.2 MAG as an important component of the myelin-derived inhibition of nerve regeneration. The acute loss of MAG function can promote significant axon growth across a site of CNS nerve damage.4

Protein Details

Purity
>95% by SDS-PAGE and analyzed by silver stain.
Endotoxin Level
<0.1 EU/µg as determined by the LAL method
Fusion Protein Tag
Fc Fusion Protein
Protein Accession No.
Amino Acid Sequence
g hwgawmpssi safegtcvsi pcrfdfpdel rpavvhgvwy fnspypknyp pvvfksrtqv vhesfqgrsr llgdlglrnc tlllstlspe lggkyyfrgd lggynqytfs ehsvldiint pnivvppevv agtevevscm vpdncpelrp elswlghegl geptvlgrlr edegtwvqvs llhfvptrea nghrlgcqaa fpnttlqfeg yasldvkypp vivemnssve aiegshvsll cgadsnpppl ltwmrdgmvl reavaeslyl dleevtpaed giyaclaena ygqdnrtvel svmyapwkpt vngtvvaveg etvsilcstq snpdpiltif kekqilatvi yesqlqlelp avtpeddgey wcvaenqygq ratafnlsve fapiillesh caaardtvqc lcvvksnpep svafelpsrn vtvneteref vysersglll tsiltlrgqa qapprvicts rnlygtqsle lpfqgahrlm wakigpdieg rmdpkscdkt htcppcpape llggpsvflf ppkpkdtlmi srtpevtcvv vdvshedpev kfnwyvdgve vhnaktkpre eqynstyrvv svltvlhqdw lngkeykckv snkalpapie ktiskakgqp repqvytlpp srdeltknqv sltclvkgfy psdiavewes ngqpennykt tppvldsdgs fflyskltvd ksrwqqgnvf scsvmhealh nhytqkslsl spgk
N-terminal Sequence Analysis
Gly20
State of Matter
Lyophilized
Predicted Molecular Mass
The predicted molecular weight of Recombinant Rat MAG is Mr 81 kDa. However, the actual molecular weight as observed by migration on SDS-PAGE is Mr 120 kDa.
Predicted Molecular Mass
81
Formulation
This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.4 with no calcium, magnesium, or preservatives.
Storage and Stability
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Country of Origin
USA
Shipping
Next Day Ambient
NCBI Gene Bank

Leinco Protein Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

Recombinant rat myelin-associated glycoprotein (MAG) offers several compelling advantages for research applications, particularly in studies involving neural regeneration, cell biology, and protein interaction research.

Key Research Applications

Neural Regeneration and CNS Studies

Recombinant rat MAG is particularly valuable for investigating axonal growth inhibition and regeneration mechanisms in the central nervous system. The protein has been instrumental in understanding how myelin-associated factors regulate neuronal growth, making it essential for studies examining spinal cord injury recovery and axonal regeneration pathways. This application is especially relevant given that the laboratory rat has made invaluable contributions to neural regeneration research.

Protein-Protein Interaction Studies

As a well-characterized recombinant protein, rat MAG can be used to study interactions with its cognate receptors and ligands. The protein's role as a sialoside-binding lectin (Siglec-4a) makes it suitable for investigating cell surface recognition events and signal transduction mechanisms in oligodendrocytes and neurons.

Practical Advantages

Cost-Effectiveness and Scalability

Recombinant rat MAG can be produced in large quantities using standard expression systems, providing researchers with abundant material at a fraction of the cost of alternative sources. This scalability is particularly important for high-throughput screening applications and extensive biochemical characterization studies.

Consistency and Quality

Recombinant proteins offer superior batch-to-batch consistency compared to native protein preparations. The standardized production ensures reproducible results across experiments, which is critical for establishing reliable baseline data and comparing results across different research groups.

Reduced Animal Use

Utilizing recombinant rat MAG significantly reduces the number of animals required for research, aligning with ethical principles of animal research minimization.

Technical Considerations

The predicted molecular weight of approximately 81 kDa makes recombinant rat MAG suitable for various analytical techniques including gel electrophoresis, size exclusion chromatography, and immunological assays. Its availability in different formats (full-length protein, Fc-chimera constructs) provides flexibility for diverse experimental designs.

Recombinant Rat MAG can be used as a standard for quantification or calibration in ELISA assays, provided that the assay is validated for its use and that key parameters such as parallelism, recovery, and specificity are confirmed.

Supporting details:

  • ELISA kits for Rat MAG commonly use recombinant Rat MAG as the standard for generating the calibration curve, as indicated in multiple kit protocols and product descriptions. These standards are typically lyophilized recombinant proteins, reconstituted and serially diluted to create the standard curve for quantification.

  • Validation is essential: The recombinant standard must be immunologically equivalent to the endogenous protein in your samples. This is assessed by parallelism (ensuring that serial dilutions of real samples yield curves parallel to the standard curve) and recovery (spiking known amounts of recombinant MAG into sample matrices and confirming accurate quantification). Without this validation, quantification may be inaccurate due to differences in antibody recognition between recombinant and native forms.

  • Best practices:

    • Use a purified recombinant protein with a well-characterized concentration, ideally quantified by an orthogonal method such as HPLC or amino acid analysis.
    • Prepare the standard curve in the same buffer or matrix as your samples to minimize matrix effects.
    • Confirm that your ELISA antibodies recognize both recombinant and endogenous MAG with similar affinity.
  • Limitations:

    • Some ELISA kits are designed to detect only native MAG and may not recognize recombinant forms equivalently. Always check the kit documentation or validate with your own controls.
    • The apparent concentration of recombinant protein in ELISA may differ from the mass on the vial label due to differences in immunoreactivity or protein quantification methods. It is recommended to assign the value of your standard based on its performance in the ELISA, not solely on the label mass.
  • Summary of requirements for use:

    • The recombinant Rat MAG must be immunologically equivalent to the endogenous protein in your samples.
    • The ELISA must be validated for quantification using this standard, including tests for parallelism and recovery.
    • The standard curve should be prepared and analyzed in the same way as your samples.

In conclusion:
You can use recombinant Rat MAG as a standard for ELISA quantification if you validate its equivalence to endogenous MAG in your assay system and follow best practices for standard curve preparation and assay calibration.

Recombinant Rat MAG (Myelin-Associated Glycoprotein) has been validated in published research for several key applications, primarily in neurobiology and immunoassays.

The most commonly validated applications include:

  • ELISA (Enzyme-Linked Immunosorbent Assay): Recombinant Rat MAG is used as a standard or spike-in control for quantifying MAG levels in biological samples such as cell culture supernatants, plasma, and serum. This application is supported by protocols where recombinant MAG is serially diluted and used to generate standard curves or assess assay performance.

  • Western Blot (WB): Recombinant Rat MAG is used as a positive control or antigen for antibody validation in Western blotting, allowing researchers to confirm antibody specificity and sensitivity for MAG detection in rat and other species.

  • Immunohistochemistry (IHC) and Immunofluorescence (IF): While most published validations focus on tissue-derived MAG, recombinant MAG is sometimes used for antibody validation or as a blocking agent in IHC and IF protocols, particularly in studies of neural tissue.

  • Protein-Protein Interaction Studies: Recombinant MAG is used in binding assays to study interactions with neuronal receptors or other glial proteins, relevant to its role in axon-glia signaling and myelination.

  • Cell Adhesion and Neurite Outgrowth Assays: Recombinant MAG has been used to study its dual role in promoting neurite outgrowth during development and inhibiting axonal regeneration in the adult nervous system. These functional assays help elucidate MAG’s biological effects on neurons.

  • Control and Blocking Reagent: In some studies, recombinant MAG serves as a blocking or neutralizing agent to dissect the specificity of MAG-mediated cellular responses.

Additional context:

  • Recombinant MAG is typically expressed in mammalian systems (e.g., HEK293 cells) to ensure proper folding and post-translational modifications, which are critical for its biological activity in functional assays.
  • While most antibody validation studies use tissue lysates, recombinant MAG is essential for standardization, calibration, and mechanistic studies where defined concentrations and purity are required.

Summary Table of Validated Applications

Application TypePurpose/Use Case
ELISAStandard curve, spike-in control, assay validation
Western Blot (WB)Positive control, antibody validation
Immunohistochemistry (IHC)/IFAntibody validation, blocking agent
Protein-Protein InteractionBinding assays, receptor-ligand studies
Cell Adhesion/Neurite OutgrowthFunctional assays for neuronal/glial biology
Blocking/NeutralizationDissecting MAG-specific effects in cellular assays

These applications are well-supported in the literature and by product datasheets, reflecting the utility of recombinant Rat MAG in both basic and translational neuroscience research.

To reconstitute and prepare Recombinant Rat MAG protein for cell culture experiments, follow these steps to ensure protein integrity and suitability for biological assays:

  1. Centrifuge the Lyophilized Protein

    • Briefly centrifuge the vial (3000–12,000 x g for 20 seconds) to collect all powder at the bottom before opening.
  2. Reconstitution

    • Use the buffer recommended in the product datasheet or Certificate of Analysis (CoA). For MAG, sterile PBS (pH 7.4) is commonly used.
    • Add buffer gently along the vial wall to avoid bubbles. Typical reconstitution concentrations are 0.1–1.0 mg/mL.
    • Do not vortex; gently mix by pipetting up and down or by gentle agitation. Let the vial sit at room temperature for 15–30 minutes until fully dissolved.
  3. Dilution for Cell Culture

    • After initial reconstitution, dilute the protein to your working concentration using cell culture medium or PBS containing a carrier protein (e.g., 0.1% BSA, 10% FBS, or 5% HSA) to stabilize the protein and prevent adsorption losses.
    • For serum-free applications, use trehalose as a stabilizer instead of animal-derived carriers.
  4. Aliquot and Storage

    • Aliquot the reconstituted protein into volumes suitable for single use (≥20 μL) to avoid repeated freeze-thaw cycles, which can reduce activity.
    • Store aliquots at -20°C to -80°C for long-term preservation.
    • For short-term use (up to one week), store at 2–8°C.
  5. Handling Precautions

    • Always wear gloves to prevent protease contamination.
    • Avoid vigorous shaking or vortexing, which can denature the protein.
    • Use sterile techniques throughout to prevent contamination.

Summary Table: Recombinant Rat MAG Protein Reconstitution

StepBuffer/ConditionKey Notes
Centrifuge vial3000–12,000 x g, 20 secCollect powder at bottom
ReconstituteSterile PBS (pH 7.4)0.1–1.0 mg/mL, gentle mixing, no vortex
Dilute for useMedium + carrier protein0.1% BSA, 10% FBS, 5% HSA, or trehalose
Aliquot & store≥20 μL, -20°C to -80°CAvoid freeze-thaw cycles
Short-term storage2–8°CUse within one week

Additional Notes:

  • Always consult the specific product datasheet or CoA for any unique requirements for your batch of MAG protein.
  • For in vivo or serum-free experiments, avoid animal-derived carriers and use trehalose as a stabilizer.

This protocol ensures optimal recovery, stability, and biological activity of recombinant MAG protein for cell culture applications.

References & Citations

1. Ming, GL. et al. (2008) Molecular Brian 1: 10
2. Kelm, S. et al. (2001) FEBS Lett. 499: 262
3. Del Rio, JA. et al. (2005) Mol Cell Neurosci. 29: 471
4. Jay, DG. et al. (2003) J of Neurosci. 23: 3112

Certificate of Analysis

IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.